Early combination lipid-lowering therapy is associated with greater achievement of goal LDL-C: Insights from the OPTIMIZE PAD-1 trial
- 27 January 2025
- journal article
- research article
- Published by SAGE Publications in Vascular Medicine
- Vol. 30 (3) , 321-323
Abstract
No abstract availableKeywords
Funding Information
- American College of Cardiology Foundation (AWD-213692)
- Amgen (20197164)
This publication has 4 references indexed in Scilit:
- Randomized Trial of a Vascular Care Team vs Education for Patients With Peripheral Artery DiseaseJACC, 2024
- 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesCirculation, 2024
- Effectiveness of Blood Lipid Management in Patients With Peripheral Artery DiseaseJACC, 2021
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular riskEuropean Heart Journal, 2019